Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2006 2
2009 2
2010 2
2011 2
2012 2
2013 3
2014 1
2015 1
2016 1
2017 4
2018 4
2019 8
2020 10
2021 9
2022 11
2023 9
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Results by year

Filters applied: . Clear all
Page 1
[Discontinuing disease-modifying therapies in multiple sclerosis].
Bernard-Valnet R, Lalive PH, Bréville G, Théaudin M, Pot C, Du Pasquier R. Bernard-Valnet R, et al. Among authors: pot c. Rev Med Suisse. 2024 Apr 24;20(871):843-847. doi: 10.53738/REVMED.2024.20.871.843. Rev Med Suisse. 2024. PMID: 38665105 French.
[Treatments for multiple sclerosis: update].
Uginet M, Lefeuvre L, Lerusse J, Pot C, Du Pasquier R, Lalive PH. Uginet M, et al. Among authors: pot c. Rev Med Suisse. 2024 Apr 24;20(871):837-842. doi: 10.53738/REVMED.2024.20.871.837. Rev Med Suisse. 2024. PMID: 38665104 Review. French.
[Anti-MOG associated disease].
Lerusse J, Uginet M, Théaudin M, Bernard-Valnet R, Pot C, Lalive PH. Lerusse J, et al. Among authors: pot c. Rev Med Suisse. 2024 Apr 24;20(871):828-832. doi: 10.53738/REVMED.2024.20.871.828. Rev Med Suisse. 2024. PMID: 38665102 French.
Complement Activation Is Associated With Disease Severity in Multiple Sclerosis.
Oechtering J, Stein K, Schaedelin SA, Maceski AM, Orleth A, Meier S, Willemse E, Qureshi F, Heijnen I, Regeniter A, Derfuss T, Benkert P, D'Souza M, Limberg M, Fischer-Barnicol B, Achtnichts L, Mueller S, Salmen A, Lalive PH, Bridel C, Pot C, Du Pasquier RA, Gobbi C, Wiendl H, Granziera C, Kappos L, Trendelenburg M, Leppert D, Lunemann JD, Kuhle J; Swiss MS Cohort Study. Oechtering J, et al. Among authors: pot c. Neurol Neuroimmunol Neuroinflamm. 2024 Mar;11(2):e200212. doi: 10.1212/NXI.0000000000200212. Epub 2024 Feb 14. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 38354323 Free article.
Traitements de la sclérose en plaques en 2024.
Pot C. Pot C. Rev Med Suisse. 2024 Jan 24;20(858):163-165. doi: 10.53738/REVMED.2024.20.858.163. Rev Med Suisse. 2024. PMID: 38268369 French. No abstract available.
Association of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With Progression Independent of Relapse Activity in People With MS.
Cagol A, Benkert P, Melie-Garcia L, Schaedelin SA, Leber S, Tsagkas C, Barakovic M, Galbusera R, Lu PJ, Weigel M, Ruberte E, Radue EW, Yaldizli Ö, Oechtering J, Lorscheider J, D'Souza M, Fischer-Barnicol B, Müller S, Achtnichts L, Vehoff J, Disanto G, Findling O, Chan A, Salmen A, Pot C, Bridel C, Zecca C, Derfuss T, Lieb JM, Remonda L, Wagner F, Vargas MI, Du Pasquier RA, Lalive PH, Pravatà E, Weber J, Cattin PC, Absinta M, Gobbi C, Leppert D, Kappos L, Kuhle J, Granziera C. Cagol A, et al. Among authors: pot c. Neurology. 2024 Jan 9;102(1):e207768. doi: 10.1212/WNL.0000000000207768. Epub 2023 Dec 13. Neurology. 2024. PMID: 38165377 Free PMC article.
25-Hydroxycholesterol in health and diseases.
Nguyen C, Saint-Pol J, Dib S, Pot C, Gosselet F. Nguyen C, et al. Among authors: pot c. J Lipid Res. 2024 Jan;65(1):100486. doi: 10.1016/j.jlr.2023.100486. Epub 2023 Dec 16. J Lipid Res. 2024. PMID: 38104944 Free PMC article. Review.
Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis.
Abdelhak A, Benkert P, Schaedelin S, Boscardin WJ, Cordano C, Oechtering J, Ananth K, Granziera C, Melie-Garcia L, Montes SC, Beaudry-Richard A, Achtnichts L, Oertel FC, Lalive PH, Leppert D, Müller S, Henry RG, Pot C, Matthias A, Salmen A, Oksenberg JR, Disanto G, Zecca C, D'Souza M, Du Pasquier R, Bridel C, Gobbi C, Kappos L, Hauser SL, Cree BAC, Kuhle J, Green AJ; UCSF, MS EPIC, and the SMSC Study Teams. Abdelhak A, et al. Among authors: pot c. JAMA Neurol. 2023 Dec 1;80(12):1317-1325. doi: 10.1001/jamaneurol.2023.3997. JAMA Neurol. 2023. PMID: 37930670
70 results